Assura Plc (LON:AGR – Get Free Report)’s share price shot up 18.1% on Monday . The company traded as high as GBX 46.20 ($0.58) and last traded at GBX 46.04 ($0.58). 186,428,844 shares were traded during trading, an increase of 1,274% from the average session volume of 13,564,649 shares. The stock had previously closed at GBX 39 ($0.49).
Assura Stock Performance
The stock’s fifty day moving average price is GBX 37.66 and its two-hundred day moving average price is GBX 39.72. The company has a market cap of £1.42 billion, a P/E ratio of -41.60, a P/E/G ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.05, a quick ratio of 2.84 and a current ratio of 0.89.
Assura Dividend Announcement
The firm also recently declared a dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, December 12th were given a GBX 0.84 ($0.01) dividend. This represents a yield of 2.12%. The ex-dividend date was Thursday, December 12th. Assura’s dividend payout ratio (DPR) is currently -286.76%.
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Recommended Stories
- Five stocks we like better than Assura
- The How and Why of Investing in Gold Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- Best Stocks Under $10.00
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.